Clinical trials
Diabetes (DM) clinical trials
Below are recruiting diabetes (dm) clinical trials, each written for real people, not researchers. We’re tracking 47 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03925714RecruitingPhase 3
Testing a gene-related approach in people with prediabetes
This trial studies how changes involving p53 and SIRT1 may affect health in people with prediabetes. It may help researchers find better ways to stop or slow progression to type 2 diabetes.
CairoAges 18 years+ - NCT07317310Recruiting
Joint health and weight loss study for knee osteoarthritis patients
This trial tests a joint health program for people with knee osteoarthritis and a BMI of 27 or higher. The goal is to see if it can improve knee pain and help with weight management.
Taipei, TaiwanAges 18–75 - NCT07702461Recruiting
Resistance training survey for people on weight loss meds
This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.
Columbus, OhioAges 18 years+ - NCT06547970Recruiting
Pharmacist education for type 1 diabetes: quality of life and adherence
This study tests whether a pharmacist-led education program can improve quality of life, medication adherence, and satisfaction for people with type 1 diabetes whose blood sugar is not well controlled. It is designed for Arabic-speaking adults and teens 16 and older.
BaghdadAges 16 years+ - NCT07119424Recruiting
SGLT2 inhibitor study for older adults
This study looks at how a class of diabetes and kidney drugs called SGLT2 inhibitors affect older adults. It aims to understand the benefits for your kidneys and metabolism.
Milan, MilanAges 65 years+ - NCT07224334RecruitingPhase 1
How cells talk to adjust insulin for weight
This study looks at how cells in the pancreas communicate to help the body produce enough insulin when you have insulin resistance (weight-related). It tests a peptide to see how this communication works.
Durham, North CarolinaAges 18–60 - NCT07237451Recruiting
Heart and kidney study of SGLT2 inhibitors
This study looks at whether a type of diabetes medicine called SGLT2 inhibitors (also known as flozins) can help protect the heart and kidneys in people with both heart failure with preserved pumping function and moderate chronic kidney disease, with or without diabetes.
IașiAges 18 years+ - NCT07426224Enrolling by invitation
Blood sugar screening for advanced gum disease patients
This trial checks if treating advanced gum disease at a specialist clinic can help find hidden high blood sugar and support you in managing your overall health.
StockholmAges 18 years+ - NCT07336316Enrolling by invitation
Heart MRI study for early heart failure with preserved pump function
This trial uses advanced MRI scans to study early signs of heart failure in people whose heart pumps normally but who have risk factors like diabetes, high blood pressure, or obesity. It aims to improve detection and understanding of this condition.
Ages Any age - NCT07192861Enrolling by invitation
Beta pilot study for type 1 diabetes with wearable devices
This study tests how well wearable devices like a smart ring and wristband can track your glucose levels. It may help you better manage your type 1 diabetes without fingersticks.
San Francisco, CaliforniaAges 18 years+ - NCT06619301RecruitingPhase 3
Insulin options for diabetes in pregnancy
This trial compares two types of insulin (glargine and NPH) to see which works better for managing blood sugar in pregnant women with gestational diabetes or type 2 diabetes. If you need to start insulin during pregnancy, you may be able to join.
Maywood, IllinoisAges 18 years+ - NCT06279637Recruiting
Diabetes support study for older African Americans and their caregivers
This study tests a joint program for older African Americans with type 2 diabetes and their caregivers. It aims to improve diabetes control through education and support sessions with a family member or friend.
Milwaukee, WisconsinAges 50–120 - NCT07316699Enrolling by invitation
Turkish Hypoglycemia Self-Care Behavior Scale Study
This trial is testing a Turkish version of a questionnaire that measures how well people manage low blood sugar. It aims to see if the scale is accurate and helpful for people with type 2 diabetes.
Bilecik, BilecikAges 18 years+ - NCT06906627Recruiting
Improving kidney screening for people with diabetes
This study helps people with type 2 diabetes get the right kidney tests to catch kidney problems early. Your doctor will check your kidney health through a simple blood and urine test.
Birmingham, AlabamaAges 18 years+ - NCT06906640Recruiting
Improving Kidney Care for People with Type 2 Diabetes
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
Birmingham, AlabamaAges 18 years+ - NCT07093476RecruitingPhase 3
Adding empagliflozin to improve blood sugar control
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
SeoulAges 19 years+ - NCT06031428RecruitingPhase 2
Nurse case management for diabetes in formerly incarcerated Black men
This trial tests a nurse-led program to help formerly incarcerated Black men better manage their type 2 diabetes. The goal is to improve blood sugar control and overall health.
Milwaukee, WisconsinAges 18 years+ - NCT06862739RecruitingPhase 4
Testing a 3-drug combination for better blood sugar control
This study tests a combination of three diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps control blood sugar in people with type 2 diabetes. It may be an option if your current treatment isn't working well enough.
Faisalabad, Punjab ProvinceAges 18–80 - NCT06954090Enrolling by invitationPhase 4
Urine test to guide early treatment in type 2 diabetes
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
Herlev, Hajdú-BiharAges 18 years+ - NCT07043426Recruiting
Diabetes care support for social needs
This study tests if connecting people with type 2 diabetes who have high A1C levels (9% or more) to community resources for social needs (like food or housing) can help improve their diabetes control. It aims to see if addressing life challenges outside the clinic helps lower blood sugar.
Boston, MassachusettsAges 18 years+ - NCT05307731RecruitingPhase 4
Fingolimod for adults with type 2 diabetes
This trial studies whether fingolimod can improve diabetes in adults with type 2 diabetes who are not yet on many medications. It will mainly check whether the drug is safe and whether it can help control blood sugar over time.
ShenyangAges 18–70 - NCT07086443RecruitingPhase 4
Testing a new wound therapy for diabetic foot ulcers
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
Monroeville, PennsylvaniaAges 18 years+ - NCT06875193RecruitingPhase 4
Comparing dapagliflozin vs pioglitazone for type 2 diabetes
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
SeoulAges 19 years+
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (dm)?
- Yes. Clin2 currently lists 47 recruiting diabetes (dm) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (dm) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (dm) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.